CalciMedica price target raised to $20 from $14 at Oppenheimer
PremiumThe FlyCalciMedica price target raised to $20 from $14 at Oppenheimer
2M ago
CalciMedica enrolls first patient in trial of Auxora in acute kidney injury
Premium
The Fly
CalciMedica enrolls first patient in trial of Auxora in acute kidney injury
2M ago
CalciMedica set to join Russell Microcap Index
Premium
The Fly
CalciMedica set to join Russell Microcap Index
3M ago
CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
PremiumPress ReleasesCalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
4M ago
CalciMedica reports Q1 EPS 1c with items, consensus (67c)
Premium
The Fly
CalciMedica reports Q1 EPS 1c with items, consensus (67c)
4M ago
CALC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CALC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
CalciMedica Advances Auxora in Kidney Injury Trial
PremiumCompany AnnouncementsCalciMedica Advances Auxora in Kidney Injury Trial
7M ago
CalciMedica: FDA clears IND application for Phase 2 trial of Auxora
Premium
The Fly
CalciMedica: FDA clears IND application for Phase 2 trial of Auxora
7M ago
Calcimedica Inc trading resumes
Premium
The Fly
Calcimedica Inc trading resumes
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100